Diocolano, Al-maarij .

HRN: 28-69-47  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2026
OXACILLIN 500MG (VIAL)
03/14/2026
03/20/2026
IV
375mg
Q6
Cellulitis
Remove - Pending Acceptance
03/14/2026
MUPIROCIN 2%, 15G (TUBE)
03/14/2026
03/21/2026
TOPICAL
2%
BID
Infected Wound
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: